Distribution of treatment for human papillomavirus-associated gynecologic carcinomas before prophylactic vaccine

Adenocarcinoma in situ and associated hu

Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine

✍ Kevin A. Ault; Elmar A. Joura; Susanne K. Kjaer; Ole-Erik Iversen; Cosette M. Wh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 243 KB

## Abstract The primary objective of this report is to describe the detection of adenocarcinoma __in situ__ (AIS) and associated human papillomavirus (HPV) type distribution that was observed in the context of two phase 3 clinical trials of a quadrivalent HPV6/11/16/18 vaccine. In this intention‐to